3D T1-weighted Black-blood Magnetic Resonance Imaging for the Diagnosis of Giant Cell Arteritis
Overview
Affiliations
Objectives: Imaging techniques have an increasing place in the diagnosis of giant cell arteritis (GCA). Achieving a confident diagnosis of GCA is often challenging and temporal artery biopsy is still considered as the gold standard despite the delayed results. 3T-MRI with 2D sequences has been evaluated for the detection of mural inflammation in extracranial arteries to support the diagnosis of GCA.
Methods: We evaluated the diagnostic performance of fat-suppressed 3D T1-weighted black-blood MRI (CUBE T1) with 3D TOF coregistration.
Results: Thirty-two patients with clinically suspected GCA were included and 10 had a diagnosis of GCA. Sensitivity and specificity of CUBE T1 were 80% and 100% respectively. Therefore, the positive predictive value of post-contrast CUBE T1 was 100% and the negative predictive value was 92%. Intra- and inter-observer agreement for mural enhancement on CUBE T1 was 1 and 0.83, respectively.
Conclusions: We demonstrate that CUBE T1 is accurate for the diagnosis of GCA. The reproducibility and short scan duration of the technique support a wider use of MRI in the diagnosis process.
Current and Emerging Approaches to Imaging Large Vessel Vasculitis.
Tawakol A, Weber B, Osborne M, Matza M, Baliyan V, Arevalo Molina A Circ Cardiovasc Imaging. 2024; 17(11):e015982.
PMID: 39561226 PMC: 11619766. DOI: 10.1161/CIRCIMAGING.124.015982.
Giant Cell Arteritis: Updates and Controversies.
Yu E, Chang J Front Ophthalmol (Lausanne). 2024; 2:848861.
PMID: 38983551 PMC: 11182101. DOI: 10.3389/fopht.2022.848861.
Brittain J, Hansen M, Carlsen J, Brandt A, Terslev L, Jensen M Diagnostics (Basel). 2024; 14(1).
PMID: 38201390 PMC: 10802188. DOI: 10.3390/diagnostics14010081.
Giant cell arteritis with severe intracranial involvement diagnosed and treated early.
Mineji K, Yako R, Toki N, Tomobuchi M, Nakao N Surg Neurol Int. 2023; 14:332.
PMID: 37810294 PMC: 10559434. DOI: 10.25259/SNI_529_2023.
Bosch P, Bond M, Dejaco C, Ponte C, Mackie S, Falzon L RMD Open. 2023; 9(3).
PMID: 37620113 PMC: 10450079. DOI: 10.1136/rmdopen-2023-003379.